Sight Sciences (SGHT) revenue and earnings history
Sight Sciences reported revenue of $77.4M for fiscal 2025 (year ended Dec 31, 2025), −3.1% on the year before, and net income of −$38.4M.
Over 5 years, from fiscal 2020 to fiscal 2025, revenue grew at a compound rate of +22.9% a year.
Revenue and net income, 6 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025ended Dec 31, 2025 | $77.4M−3.1% | −$37.1M | −$38.4M | −$29.7M | $224K | −$29.9M | $13.1M | — | — | $92M | $42.4M | 10-K |
| 2024ended Dec 31, 2024 |
The latest quarter, insider trades and fund moves: Sight Sciences (SGHT) on OQRO.
Common questions
What was Sight Sciences's revenue in fiscal 2025?
$77.4M for the year ended Dec 31, 2025, as reported in its 10-K filed Mar 4, 2026. That is −3.1% on fiscal 2024 ($79.9M).
How fast has Sight Sciences's revenue grown?
From $27.6M in fiscal 2020 to $77.4M in fiscal 2025: a compound annual growth rate of +22.9% over 5 years. This is arithmetic on the filed figures and says nothing about the years ahead.
Has Sight Sciences been profitable?
Where these figures come from
The SEC’s companyfacts data: every figure Sight Sciences tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.